Abstract
Newly developed substrate analogue peptidomimetics are able to inhibit the human immunodeficiency virus, HIV-1 proteinase at nanomolar concentration. In HIV infected cell culture they exhibit antiviral activity. We have analyzed the non-infectious HIV particles produced in chronically HIV infected cell culture in presence of one of these inhibitors. The total production of virus particles was not substantially reduced in drug treated cultures, compared to non-inhibited control cultures, but the infectivity of these virus particles was reduced about 100 fold. The processing of gag and gag-pol protein precursor was inhibited; only borderline activity of reverse transcriptase (RT) could be detected in these particles and they contained nonprocessed gag precursor protein. Thin section electron microscopy of inhibitor-treated, HIV-infected cells revealed reduced viral cytopathogenicity and both inhibition of particle assembly and incomplete maturation of the particles formed. The HIV particles produced in the presence of the proteinase inhibitor were studded with envelope glycoprotein knobs and often comprised multiple budding regions, but were morphologically immature.
MeSH Terms
Antiviral Agents/pharmacology
Cell Line
Dipeptides/pharmacology
Gene Products, gag/metabolism
HIV Protease Inhibitors
HIV-1/drug effects,pathogenicity,ultrastructure
Humans
Protein Precursors/metabolism
Chemicals
Antiviral Agents
Dipeptides
Gene Products, gag
HIV Protease Inhibitors
Protein Precursors
EMD 57464
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Schätzl H
Max-von-Pettenkofer-Institut, Universität München, Federal Republic of Germany.
Gelderblom H R
Nitschko H
von der Helm K
References (18)
18 references, click to expand
-
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6
PMID: 3045820
-
Properties of avian retrovirus particles defective in viral protease.
J Virol. 1990 Oct;64(10):5076-92
PMID: 1697912
-
Rational design of peptide-based HIV proteinase inhibitors.
Science. 1990 Apr 20;248(4953):358-61
PMID: 2183354
-
Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.
J Virol. 1988 Nov;62(11):4393-7
PMID: 3050149
-
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
Virology. 1987 Jan;156(1):171-6
PMID: 3643678
-
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.
Science. 1990 Aug 3;249(4968):527-33
PMID: 2200122
-
Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
FEBS Lett. 1989 Apr 24;247(2):349-52
PMID: 2469601
-
An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7472-6
PMID: 2217178
-
Morphogenesis and morphology of HIV. Structure-function relations.
Arch Virol. 1989;106(1-2):1-13
PMID: 2669684
-
Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.
J Virol. 1989 Jun;63(6):2550-6
PMID: 2657099
-
Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.
Cell. 1988 Jul 29;54(3):363-8
PMID: 3293801
-
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Nature. 1990 Jan 4;343(6253):90-2
PMID: 1688646
-
Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.
EMBO J. 1988 Jun;7(6):1785-91
PMID: 3049075
-
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
Science. 1990 Jan 26;247(4941):454-6
PMID: 2405486
-
Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
N Engl J Med. 1989 Dec 14;321(24):1621-5
PMID: 2586564
-
Active human immunodeficiency virus protease is required for viral infectivity.
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90
PMID: 3290901
-
Plasma viremia in human immunodeficiency virus infection.
N Engl J Med. 1989 Dec 14;321(24):1626-31
PMID: 2511447
-
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
J Virol. 1990 Oct;64(10):5230-4
PMID: 2204725